(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...
Hyperinflation refers to the lung’s increase in size due to the trapped air that has caused them to expand. The BREATHE-3 trial uses self-expanding nitinol airway scaffolds that are placed ...
Readers were most interested in how pulmonary rehabilitation referrals and discharge disposition differ with vs. without use of an inpatient COPD clinical pathway embedded directly into the electronic ...
According to the World Health Organisation, chronic obstructive pulmonary disease is the fourth-leading cause of death globally. Yet even with this statistic, COPD continues to be extensively ...
Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved statistically significant and clinically meaningful reductions in the a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results